ELEVAI LABS INC.

Other languages Elevai Labs Inc.

Equities

ELAB

US28622K1043

Market Closed - Nasdaq Other stock markets 02:00:00 06/06/2024 am IST			5-day change	1st Jan Change
0.651 ^USD	-2.11%		-2.11%	-64.39%

19/05	Certain Common Stock of Elevai Labs, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024.	CI
15/05	Elevai Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Elevai Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
Elevai Biosciences Inc. Highlights Preclinical Data Showing Potential of In-Licensed Asset ?EL-22? for The Treatment of Obesity	02/05
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries	02/05
Elevai Labs Inc. Announces Executive Changes	02/05
Elevai Labs Enters into Exclusive Licensing Agreement with MOA Life Plus Co., Ltd to Develop and Commercialize Two Novel Assets for the Treatment of Obesity and Muscle Loss Prevention	01/05
Elevai Labs, Inc. Enters the Taiwan Market with Signing of 5Th International Distribution Agreement in 14 Months	22/04
Elevai Labs, Inc. Launches E-Commerce Portal	18/03
Elevai Labs, Inc. Announces Board Changes	08/03
Elevai Labs, Inc. Announces New Partnership with Skin Sana Ltd	07/12
Elevai Labs, Inc. Enters into Licensing Agreement with Yuva Biosciences, Inc. to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products	29/11
Sector Update: Health Care Stocks Higher Friday Afternoon	24/11
Elevai Labs Closes IPO, Raises $6 Million	24/11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer